Insulet (PODD) News Today → Central Bank Gold Heist In Progress (From Colonial Metals) (Ad) Free PODD Stock Alerts $171.68 +5.82 (+3.51%) (As of 03/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePODD Apr 2024 135.000 callfinance.yahoo.com - March 17 at 11:30 PMInsulet’s Growth Trajectory Affirmed with a Buy Rating and Revised Target Pricemarkets.businessinsider.com - March 16 at 8:36 PMPODD Apr 2024 165.000 callfinance.yahoo.com - March 15 at 10:56 PMPODD Apr 2024 190.000 putfinance.yahoo.com - March 15 at 10:56 PMHudson Bay Capital Management LP Purchases New Stake in Insulet Co. (NASDAQ:PODD)marketbeat.com - March 15 at 7:18 AMPODD Jan 2025 180.000 callfinance.yahoo.com - March 15 at 2:32 AMWilliam Blair Comments on Insulet Co.'s Q1 2024 Earnings (NASDAQ:PODD)americanbankingnews.com - March 14 at 6:24 AM93,402 Shares in Insulet Co. (NASDAQ:PODD) Bought by Comerica Bankmarketbeat.com - March 14 at 5:30 AMInsulet Co. to Post Q1 2025 Earnings of $0.62 Per Share, William Blair Forecasts (NASDAQ:PODD)americanbankingnews.com - March 14 at 1:48 AMPolar Capital Holdings Plc Reduces Stock Position in Insulet Co. (NASDAQ:PODD)marketbeat.com - March 13 at 7:54 AMWilliam Blair Comments on Insulet Co.'s Q1 2025 Earnings (NASDAQ:PODD)marketbeat.com - March 13 at 6:49 AMInsulet Co. (NASDAQ:PODD) Shares Purchased by Graham Capital Management L.P.marketbeat.com - March 12 at 10:01 AMCalculating The Fair Value Of Insulet Corporation (NASDAQ:PODD)finance.yahoo.com - March 11 at 6:26 PMTimesSquare Capital Management LLC Purchases Shares of 23,000 Insulet Co. (NASDAQ:PODD)marketbeat.com - March 11 at 9:50 AMInsulet Co. (NASDAQ:PODD) Shares Purchased by Toroso Investments LLCmarketbeat.com - March 10 at 8:15 AMAre These 5 Undervalued Stocks Ready to Break Out?marketbeat.com - March 8 at 9:11 AMAre These 5 Undervalued Stocks Ready to Break Out? (PODD)marketbeat.com - March 8 at 9:10 AMInsulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapyfinance.yahoo.com - March 8 at 7:55 AMInsulet's Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapybusinesswire.com - March 8 at 6:00 AMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Insulet (PODD) and Adaptimmune Therapeutics (ADAP)markets.businessinsider.com - March 7 at 10:19 AMNatixis Advisors L.P. Decreases Stock Holdings in Insulet Co. (NASDAQ:PODD)marketbeat.com - March 7 at 5:30 AMInsulet Co. (NASDAQ:PODD) Shares Sold by Schonfeld Strategic Advisors LLCmarketbeat.com - March 6 at 6:45 AMInsulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)businesswire.com - March 5 at 6:06 AMInsulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)businesswire.com - March 5 at 6:00 AMIs It Time to Buy the S&P 500's 3 Worst-Performing February Stocks?fool.com - March 4 at 5:30 AMEnvestnet Asset Management Inc. Grows Stock Holdings in Insulet Co. (NASDAQ:PODD)marketbeat.com - March 1 at 4:54 AMDeerfield Management Company L.P. Series C Purchases New Position in Insulet Co. (NASDAQ:PODD)marketbeat.com - February 28 at 2:11 PM44,961 Shares in Insulet Co. (NASDAQ:PODD) Acquired by Trexquant Investment LPmarketbeat.com - February 27 at 9:58 AMWestfield Capital Management Co. LP Has $101.64 Million Position in Insulet Co. (NASDAQ:PODD)marketbeat.com - February 26 at 11:38 AMInsulet’s Strong Growth and Market Position Justify Buy Rating Despite Short-Term Revenue Guidance Concernsmarkets.businessinsider.com - February 26 at 9:43 AMBarclays Sticks to Its Hold Rating for Insulet (PODD)markets.businessinsider.com - February 26 at 12:07 AMNumerai GP LLC Sells 10,960 Shares of Insulet Co. (NASDAQ:PODD)marketbeat.com - February 25 at 10:28 AMInsulet Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - February 24 at 9:04 AMFederated Hermes Inc. Sells 14,492 Shares of Insulet Co. (NASDAQ:PODD)marketbeat.com - February 24 at 7:49 AMAnalyst Scoreboard: 5 Ratings For Insuletmarkets.businessinsider.com - February 23 at 5:15 PMInsulet Corporation (NASDAQ:PODD) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 23 at 5:15 PMInsulet (NASDAQ:PODD) Announces Quarterly Earnings Results, Beats Estimates By $0.73 EPSmarketbeat.com - February 23 at 2:01 PMInsulet (NASDAQ:PODD) Given New $225.00 Price Target at JPMorgan Chase & Co.marketbeat.com - February 23 at 1:44 PMSprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024marketbeat.com - February 23 at 12:32 PMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Penumbra (PEN), BioMarin Pharmaceutical (BMRN) and Insulet (PODD)markets.businessinsider.com - February 23 at 12:14 PMQ4 2023 Insulet Corp Earnings Callfinance.yahoo.com - February 23 at 12:14 PMInsulet (NASDAQ:PODD) Shares Gap Down to $197.14marketbeat.com - February 23 at 11:54 AMInsulet Co. (NASDAQ:PODD) Receives Average Recommendation of "Moderate Buy" from Brokeragesmarketbeat.com - February 23 at 3:56 AMInsulet forecasts weak annual revenue growth; shares dropmsn.com - February 23 at 2:11 AMInsulet beats quarterly profit estimates on strong demand for insulin pumpsmsn.com - February 22 at 9:07 PMInsulet Non-GAAP EPS of $1.40 beats by $0.74, revenue of $509.8M beats by $48.74Mmsn.com - February 22 at 9:07 PMInsulet Corp (PODD) Reports Robust Full Year and Q4 2023 Financial Resultsfinance.yahoo.com - February 22 at 9:07 PMDexCom- A Winner in Diabetes Managementfinance.yahoo.com - February 22 at 1:08 PMIs It Too Late To Consider Buying Insulet Corporation (NASDAQ:PODD)?finance.yahoo.com - February 22 at 8:07 AM4,402 Shares in Insulet Co. (NASDAQ:PODD) Purchased by CenterBook Partners LPmarketbeat.com - February 22 at 7:45 AM Get Insulet News Delivered to You Automatically Sign up to receive the latest news and ratings for PODD and its competitors with MarketBeat's FREE daily newsletter. Email Address AI Cracks Open Largest Untapped Energy Reserve on Earth (Ad)This orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… ]click here to watch a free presentation where I reveal all the details of this lucrative opportunit PODD Media Mentions By Week PODD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PODD News Sentiment▼0.850.64▲Average Medical News Sentiment PODD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PODD Articles This Week▼188▲PODD Articles Average Week Get Insulet News Delivered to You Automatically Sign up to receive the latest news and ratings for PODD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Teleflex News Globus Medical News NovoCure News Baxter International News ResMed News Penumbra News Shockwave Medical News Inspire Medical Systems News Merit Medical Systems News Glaukos News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PODD) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insulet Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.